CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD
Public ClinicalTrials.gov record NCT00641329. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase III Evaluation of the Safety and Efficacy of CLONICEL (Clonidine HCl Sustained Release) as Add-on to Psychostimulant Medication vs. Psychostimulant Medication Alone in Children and Adolescents With ADHD
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if CLONICEL (clonidine HCl sustained release) is a safe and effective add-on to psychostimulant therapy in children and adolescents with attention deficit hyperactivity disorder (ADHD).
Study identification
- NCT ID
- NCT00641329
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 198 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2008 (Type not available)
- Primary completion
- Feb 2009 (Actual)
- Completion
- Feb 2009 (Actual)
- Last update posted
- Apr 9, 2010
2008 – 2009
United States locations
- U.S. sites
- 23
- U.S. states
- 13
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | El Centro | California | 92243 | — |
| Not listed | Irvine | California | 92612 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | Bradenton | Florida | 34208 | — |
| Not listed | Lauderhill | Florida | 33319 | — |
| Not listed | Miami | Florida | 33161 | — |
| Not listed | Bardstown | Kentucky | 40004 | — |
| Not listed | Baltimore | Maryland | 21208 | — |
| Not listed | St Louis | Missouri | 63005 | — |
| Not listed | Clementon | New Jersey | 08021 | — |
| Not listed | Chapel Hill | North Carolina | 27514 | — |
| Not listed | Durham | North Carolina | 27705 | — |
| Not listed | Cleveland | Ohio | 44106 | — |
| Not listed | Oklahoma City | Oklahoma | 73103 | — |
| Not listed | Oklahoma City | Oklahoma | 73116 | — |
| Not listed | Houston | Texas | 77007 | — |
| Not listed | Houston | Texas | 77074 | — |
| Not listed | Lake Jackson | Texas | 77566 | — |
| Not listed | Wharton | Texas | 77488 | — |
| Not listed | Clinton | Utah | 84015 | — |
| Not listed | Kirkland | Washington | 98033 | — |
| Not listed | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00641329, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 9, 2010 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00641329 live on ClinicalTrials.gov.